Loading...
Trading.HK
Global Markets
T.HK
News Markets

Menu

Home
Asia
Hong Kong China Japan India Singapore Taiwan
Americas
US Canada Brazil Mexico
Europe & Others
UK Germany France Australia
View All Markets →
Traditional Assets
Equities Options ETFs Bonds
Alternative Assets
Cryptocurrency Forex Commodities Macro Indicators
News
Market Analysis
Correlation Matrix Risk-Return Profile Market Sentiment Momentum Signals
View All Analytics →
Screener Compare Search Market Status
/ News / Markets

News

All News
By Category
Central Banks Commodities Corporate Corporate Actions Crypto Cryptocurrency Dividends Earnings Economic Data Forex IPOs Insider Trading Legal M&A Macro Market Update Markets Ratings Regulations Technology
Coverage
Methodology
FAQ

Suriname could receive another $500 million from IDB in next year, Goldfajn says

Published 2 months ago • Aug 13, 2025 at 12:05 AM • Neutral
Suriname could receive another $500 million from IDB in next year, Goldfajn says
Auto

Related Stocks

AAPL.US Apple Inc
PARAMARIBO (Reuters) -The Inter-American Development Bank (IDB) could approve another $500 million, on top of the $500 million already signed off on, for Suriname within the next year, the lender’s head said on Tuesday.

IDB President Ilan Goldfajn, speaking from the South American nation, said that the additional credit would be pending authorities’ approval.

More News

Florida Brain Injury Lawyer Joe Osborne Discusses Birth-Related Brain Injuries on Coffee With Q Show

16 minutes ago Neutral

Britons set to spend £4bn more this Black Friday despite scam fears

1 hour ago Neutral

Avance Clinical, ‘신장 및 심대사 질환 우수 센터’ 설립하며 환자 모집 최적화 통해 임상시험 성공률 제고에 박차

1 hour ago Neutral

Avance Clinical 成立腎臟與心血管代謝卓越中心,優化患者招募流程以提升研究成功率

1 hour ago Neutral

Avance Clinical 宣布成立肾脏与心血管代谢卓越中心,优化患者招募以提升研究成功率

1 hour ago Neutral

Trading.HK

Your comprehensive platform for global financial markets data, analytics, and insights.

Markets

  • Asia Pacific
  • Americas
  • Europe
  • Market Status

Asset Classes

  • Equities
  • Cryptocurrency
  • ETFs
  • Forex
  • Commodities

Resources

  • Market News
  • Analytics
  • Stock Screener
  • Compare Stocks
  • Methodology
  • Coverage
  • FAQ

© 2025 Trading.HK. All rights reserved.

Privacy Policy Terms of Service Contact